21.72
전일 마감가:
$21.12
열려 있는:
$20.65
하루 거래량:
297.32K
Relative Volume:
0.50
시가총액:
$44.69M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-37.94%
1개월 성능:
+87.73%
6개월 성능:
+434.98%
1년 성능:
+0.00%
Quantum Biopharma Ltd Stock (QNTM) Company Profile
QNTM을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
QNTM
Quantum Biopharma Ltd
|
21.72 | 44.69M | 0 | 0 | 0 | 0.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
441.30 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
521.00 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
322.83 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
560.14 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
241.20 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Quantum Biopharma Ltd 주식(QNTM)의 최신 뉴스
Singular Research Reports on Quantum BioPharma Ltd.'s Strategic Advances and Pipeline Progress - Newsfile
Keg, LQWD, Quantum at 52-Week Highs on News - Baystreet.ca
Quantum BioPharma Ltd. Initiates Groundbreaking MS Study with Massachusetts General Hospital - citybuzz -
Quantum BioPharma Says First Person With Multiple Sclerosis Scanned in Joint Study With Hospital - MarketScreener
Quantum BioPharma and MGH Launch MS Study with Novel Imaging Technique - TipRanks
Quantum BioPharma (QNTM) Initiates MS Imaging Study with Massachusetts General | QNTM Stock News - GuruFocus
Quantum BioPharma Announces First Person with Multiple - GlobeNewswire
Revolutionary MS Brain Imaging Study Launches at Harvard's MGH: First Patient Milestone Achieved - Stock Titan
Quantum BioPharma Ltd. Announces Special Dividend Linked to Litigation Proceeds - citybuzz -
Quantum BioPharma (QNTM) Announces Special Dividend in CVRs | QN - GuruFocus
Quantum BioPharma boosts investments in digital assets to $5M - MSN
Quantum BioPharma plans special dividend tied to legal action By Investing.com - Investing.com South Africa
Quantum BioPharma plans special dividend tied to legal action - Investing.com
Quantum Biopharma Plans Special Dividend Linked to Potential Litigation Proceeds - marketscreener.com
Quantum BioPharma Announces Special Dividend Linked to Litigation Proceeds - TipRanks
Quantum BioPharma Ltd. Announces Special Dividend of Contingent Value Rights Linked to Ongoing Litigation Against Banks - Nasdaq
Quantum BioPharma Announces Intention to Declare Special - GlobeNewswire
Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds - GlobeNewswire Inc.
Quantum BioPharma Boosts Digital Asset Holdings To $5 Million With New Bitcoin Purchase - Bitcoin Magazine
Quantum Biopharma Purchases More Bitcoin Bringing Total Investment In Digital Assets To USD $5,000,000 - marketscreener.com
Quantum BioPharma (QNTM) Expands Cryptocurrency Holdings to $5 M - GuruFocus
Quantum BioPharma Expands Cryptocurrency Investment Portfolio - TipRanks
Quantum Biopharma Purchases More Bitcoin (BTC) Bringing the Total Investment in Digital Assets to USD $5,000,000 - GlobeNewswire
Quantum Biopharma Brief: Says Purchased More Bitcoin (BTC) Bringing Total Investment in Digital Assets to US$5 Million - marketscreener.com
Quantum Biopharma buys additional $1 million of Bitcoin, other cryptocurrencies - MSN
Quantum BioPharma clarifies misinformation on stock name, RTO rumors By Investing.com - Investing.com South Africa
Quantum BioPharma Ltd. Clarifies Misinformation Regarding Name Change and RTO Rumors - citybuzz -
Quantum BioPharma Clarifies Name Confusion, Refutes RTO Rumors With Unbuzzd Wellness - Nasdaq
Quantum BioPharma Clarifies It Has Not Changed Its Name | QNTM S - GuruFocus
Quantum BioPharma clarifies misinformation on stock name, RTO rumors - Investing.com
Quantum BioPharma clarifies company has not changed its name - TipRanks
Quantum BioPharma (QNTM) Clarifies Company Name and Transaction Rumors | QNTM Stock News - GuruFocus
Quantum BioPharma Addresses Misinformation and Financial Agreements - TipRanks
Quantum BioPharma Clarifies It Has Not Changed Its Name | QNTM Stock News - GuruFocus
Quantum BioPharma Addresses Misinformation Regarding Unbuzzd Wellness and Clarifies Stock Trading Platform Errors - Nasdaq
Quantum BioPharma Clarifies It Has Not Changed Its Name - GlobeNewswire
Quantum BioPharma Sets Record Straight: No Name Change, Reveals Major Unbuzzd Wellness Stake - Stock Titan
iNGENū CRO Partners with Quantum BioPharma to Launch - GlobeNewswire
Quantum BioPharma settles disputes with former CEO By Investing.com - Investing.com South Africa
Quantum BioPharma Resolves Legal Dispute with Former CEO, Secures $2.35 Million Settlement - citybuzz -
What's Going On With Quantum Biopharma Stock Today? - Benzinga
Quantum BioPharma (QNTM) Settles Disputes with Former CEO | QNTM Stock News - GuruFocus
Quantum BioPharma Settles Legal Dispute with Former CEO, Receives $2.35 Million - TipRanks
Quantum BioPharma settles disputes with former CEO - Investing.com
Quantum Biopharma Brief: Says Received US$2.35 Million From a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari - marketscreener.com
Quantum BioPharma Receives $2.35 Million USD from a - GlobeNewswire
Quantum BioPharma Ends 4-Year Legal Battle with $2.35M Settlement Payment from Ex-CEO - Stock Titan
Quantum BioPharma appoints MNP for IPO readiness audits By Investing.com - Investing.com South Africa
Unbuzzd Wellness Prepares for Potential IPO with New Auditor Appointment - citybuzz -
Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit - GuruFocus
Quantum BioPharma (QNTM) Engages New Auditor for Potential IPO | - GuruFocus
Quantum Biopharma Ltd (QNTM) 재무 분석
Quantum Biopharma Ltd (QNTM)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):